# WayForward Health Pvt

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wayforward-health-pvt

- Industry: Healthcare Specialists
- Headquarters: New York, US
- Website: www.wayforward.co.in
- Total disclosed funding: $2.2M
- Latest round: Seed (Jun 1, 2020)
- Investors on record: 2

## About

WayForward Health Pvt Ltd, based in New York, US, specializes in providing innovative health technology solutions that enhance operational efficiency and user engagement across various sectors.WayForward Health Pvt Ltd was founded in 2015 in New York, US, focusing on health technology solutions. The company has undergone strategic developments to cater to evolving client needs. Co-founded by Ritvik Singh and Stan Miroshnikov, Ritvik Singh serves as the CEO. The company was acquired in May 2021 by DarioHealth Corp. for USD 30.0 mn, marking a significant transition in ownership and strategy.WayForward Health Pvt Ltd delivers a suite of innovative products aimed at enhancing operational efficiency and user experiences. Their offerings are tailored for industries requiring robust technological infrastructure, addressing challenges like data management and process automation. The company serves clients across North America, Europe, and Asia, including small and medium-sized enterprises as well as larger corporations, ultimately facilitating improved productivity and decision-making.WayForward Health Pvt Ltd generates revenue through a combination of subscription-based services and transactional sales. Clients pay recurring fees for access to flagship products, while also engaging in one-time purchases. This flexible pricing structure allows businesses to choose plans that fit their needs. Additionally, the company engages in B2B transactions, providing customized technological solutions.WayForward Health Pvt Ltd intends to leverage its recent acquisition to expand its product offerings and enhance market reach. The company is planning to introduce new health technology products in the upcoming year to cater to emerging market needs. Moreover, WayForward aims to penetrate additional markets within Europe and Asia by the end of 2022. The recent funding from the Trade Sale, amounting to USD 30.0 mn, will be utilized to support these initiatives, ensuring the company's alignment with evolving client demands and market trends.

## Funding rounds

- Seed, Jun 1, 2020, $2.2M — Leo Capital, Epsilon Health Investors

## Investors

- Leo Capital (https://capitalatlas.ai/funds/leo-capital) — Seed
- Epsilon Health Investors (https://capitalatlas.ai/funds/epsilon-health-investors) — Seed